I-80 Gold 4Q Rev $25.8M; 4Q Adj Loss/Shr 7c; 4Q Gold Sales of 3,350 Oz at Realized Price of $1,996 Per Oz - ISC Reports Record Revenue, Adjusted Ebitda for 2023; 2023 EPS C$1.39 Vs. EPS. -March 13, 2024 at 06:20 am EDT
- MarketScreener
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 42,000 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $1.74, for a total value of $73,080.00. Following the completion of the sale, the chairman now owns 1,453,543 shares […]
/PRNewswire/ Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients.
Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients.